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Lung cancer caused by polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs and related
environmental agents is a major problem in industrialized nations. The high case-fatality rate of
the disease, even with the best supportive treatment, underscores the importance of primary
lung cancer prevention. Development of biomarkers of exposure and effects to PAHs and related
compounds is now underway and includes measurement of urinary metabolites of specific PAHs
as well as detection of protein and DNA adducts as indicators of effective dose. Validation of these
markers in terms of total environmental dose requires that concurrent measures of air levels and
potential dermal exposure be made. In addition, the interrelationships between PAH biomarkers
must be determined, particularly when levels of the marker in surrogate molecules (e.g., protein)
or markers from surrogate tissues (e.g., lymphocyte DNA) are used to assess the risk to the target
organ, the lung. Two approaches to biomarker studies will be reviewed in this article: the progress
made using blood lymphocytes as surrogates for lung tissues and the progress made developing
noninvasive markers of carcinogen-DNA adduct levels in lung-derived cells available in
bronchial-alveolar lavage and in sputum. Data are presented from studies in which exfoliated
urothelial cells were used as a surrogate tissue to assess exposure to human urinary bladder
carcinogens in occupational groups. Environ Health Perspect 104(Suppl 5):901-906 (1996)
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Introduction
Lung cancer remains one of the most
serious and troubling environmental dis-
eases. The overlapping causes and patho-
genesis of the disease make it difficult to
estimate the proportion of lung cancer
cases attributable to the ambient environ-
ment versus those caused by specific agents
such as tobacco smoking. However,
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epidemiological evidence suggests that sev-
eral occupational groups are at significantly
increased risk for developing lung cancer,
including populations exposed to poly-
cyclic aromatic hydrocarbons (PAHs) such
as coke oven workers and steelworkers (1).
Table 1 gives a list of the agents identified
or strongly suspected ofbeing occupational
lung carcinogens, Table 2 gives a list of
occupational groups with potential expo-
sure to coal tar, and Table 3 lists complex
mixtures containing PAHs. Clearly, there
are numerous people in the general popula-
tion as well as in specific occupational
groups who might be exposed to these
agents. The focus of this article is the
advances that have been made in develop-
ing biomarkers of exposure and effect for
PAH lung carcinogens and how these
markers can provide a framework relevant
to the study and prevention of occupa-
tional and environmental disease.
Lung cancer is an important disease in
the United States and around the world.
There were 885,000 cases and 770,000
deaths from lung cancer worldwide in
1985, the last year for which complete sta-
tistics are available (2). The lung is the site
of 11.9% ofall tumors worldwide, making
lung cancer the most common neoplastic
disease in the world. In the United States,
lung cancer accounts for 28% of all can-
cers. There were 170,000 cases of lung
cancer in the United States in 1993 and
149,000 deaths (3). There is virtually no
difference in the 5-year survival rate in the
United States and the rest of the world;
87% oflung cancer cases are fatal within 5
years. Thus, an educated public and the
availability ofmodern medical treatment to
provide early diagnosis and treatment have
had virtually no impact on the course of
this disease.
It has been estimated that 76% of all
U.S. lung cancer cases are due to tobacco
smoking (4). The trends for tobacco sales
and lung cancer rates are positively corre-
lated within a 20- to 25-year latency period
(3). Cigarette sales to American females
have increased in the last 20 years, and
there seems to be a nascent increase in the
rate of lung cancer in this group. It is
difficult to differentiate cases oflung cancer
arising from environmental exposure from
those due to smoking. This stems from the
fact that while there is a fairly large list of
occupational and environmental lung car-
cinogens (Table 1), the majority ofpersons
at risk are exposed to soots, tars, combus-
tion products, and other complex mixtures
that have similar chemical composition to
tobacco smoke. Therefore, the specific
chemical agents that cause lung cancer from
smoking and those caused by most environ-
mental exposures are likely to be the same
or closely related. Moreover, the "trail" left
by both these exposures in terms ofdisease
or biomarkers are similar. The potential for
interaction (potentiation, additive, and syn-
ergistic effects) between occupational and
environmental exposures has made it
difficult to assess the proportion of total
lung cancers directly attributable to the
general environment. The effect ofoccupa-
tional exposure within certain groups is
profound; some exposed workers have been
shown to be at 10 to 50 times greater risk
than controls (1,5).
There are several important reasons why
the development ofbiomonitoring methods
is highly desirable for environmental lung
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Table 1. Occupational lung carcinogens.
Arsenic Soots and tars
Asbestos Uranium
Bis(chloromethyl)ether Vinyl chloride
Chloromethyl ethyl ether Beryllium
Chromates Cadmium
Coke oven emissions Chloroprene
Mustard gas Lead
Nickel Tobacco smoke
Table2. Occupations with potential exposureto coal tar.
Asphalt workers Boat builders
Briquette maker Coal tarworkers
Coke oven workers Pavers
Creosoters Electrode makers
Flue cleaners Furnace workers
Pitch workers Railroad trackworkers
Road workers Roofers
Shinglemakers Tile pressers
Waterproofers Rubberworkers
Table 3. Some complex mixtures containing polycyclic
aromatic hydrocarbons.
Coal tar pitch Coke oven tar
Aluminum reduction Tobacco smoke
electrodes Marijuana smoke
Asphalt and crumb Combustion products,
rubberasphalt in general (e.g.,
Used gasoline engine oil foundries)
Roofing tar
cancer and environmental lung carcinogens.
A primary responsibility ofenvironmental
health professions is to prevent environ-
mental disease. Lung cancer advances in
discrete premalignant stages including
hyperplasia, metaplasia, dysplasia and carci-
noma in situ. Ifbiomarkers could be found
that indicate earlier stages, it would be pos-
sible to use preventive measures (e.g., vita-
min or nutrient therapy) to halt the
progress ofthe disease. On the other hand,
there is some doubt that secondary preven-
tion of this type would be useful because,
even with early detection as currently
defined, the mortality rate from lung
cancer is extremely high. In addition, there
is strong evidence for the theory of "field
cancerization" with lung cancer (6). This
theory is based on the random probability
ofcritical mutations in populations ofcells
in the lung exposed to carcinogens. After
exposure ofeither longer duration or mag-
nitude, all the cells will sustain mutagenic
hits, and there is increasing probability that
there will be multiple, independent
tumors. To support this theory, it has been
shown that the lungs ofpersons with pri-
mary tumors have many areas of aneu-
ploidy and other atypical molecular and
cytogenetic markers distant from the pri-
mary tumor (6). In addition, it has been
reported that about 50% oflong-term sur-
vivors oflung cancer develop new primary
tumors. These data reinforce the notion
that primary prevention is the major tool
against lung cancer.
The major promise for biomarkers of
environmental carcinogens is their poten-
tial use in primary prevention as sentinels
ofsignificant exposure and early effects of
carcinogens; biomarkers can also be used to
guide and monitor the efficacy ofexposure
intervention strategies. Figure 1 displays a
model for a linear relationship between
exposure and disease with several interven-
ing stages. Ifbiomarkers are available rep-
resent these stages, they can be exploited to
characterize exposure in an increasingly
selective way relative to disease. It is clear
from the graph that the doser a marker to
the occurrence ofthe disease, the better its
ability to predict the disease. On the other
hand, implicit in Figure 1 is the possibility
that certain markers may be too closely
related to disease outcome to be useful in
prevention. Carcinogen biomarkers should
measure an event in the disease process,
making it biologically relevant to the dis-
ease. Measurement of the marker should
also accommodate individual differences in
exposure and susceptibility. The marker
should be readily detectable and show a
dose response with measurement of exter-
nal dose. An important criterion for a
marker in environmental health is that the
marker measure either a reversible event or
one that has a low probability ofresulting
in disease so that ifinterventions are used,
both the level ofthe marker and the risk of
disease will be decreased.
Although exposures to tobacco smoke
are via inhalation, this is not necessarily true
for all environmental PAH carcinogens. In
manycases dermal absorption is a significant
component oftotal exposure. Relying on air
monitoring for exposure assessment is
fraught with error ifdermal exposure plays a
significant role. This occurrence has best
been documented for the aromatic amine-
induced urinary bladder carcinogens in dye
and rubber workers, but the evidence
increasingly suggests that this may also be
true for exposure to other carcinogens (7).
For example, young children may be
exposed via the dermal and oral routes as
they crawl on contaminated surfaces and
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Figure 1. Model for a linear relationship between
exposure and disease with intervening stages.
place contaminated objects in their mouths.
Recent preliminary data indicated that
children had higher levels ofPAH metabo-
lites in their urine than their mothers (8).
Biological monitoring can estimate total
internal dose from all routes ofexposure.
Since the carcinogenicity ofmany exposures
is now recognized, personal protective
equipment is often used to reduce exposure.
However, there is a wide variation in the
proper use ofsuch equipment, and there is
almost no use ofprotection by persons in
the general population. By taking biological
samples ofthe internal dose ofthe exposure,
the efficacy ofthe protective devices can be
measured in the exposed persons.
PAHs andNltro-PAHs inAmbientAir
and CertainOccupations
The presence of polycyclic aromatic
hydrocarbons such as benzo[a]pyrene
(B[a]P), a major component of combus-
tion-generated particulates in polluted
ambient air, is well established, as are the
carcinogenic and mutagenic properties of
these materials. The role of nitrous com-
pounds, specifically the nitro-PAHs,
which are known to be direct mutagens,
has not been investigated as thoroughly.
Better information regarding atmospheric
sources, diurnal and seasonal fluctuations
in air levels, half-lives, and isolation and
identification of the nitro-PAH com-
pounds as related to exposure and accurate
risk assessment is needed.
Nitro-PAH compounds are generated
by diesel and gasoline-powered engines and
appear in the exhausts ofthese engines (9).
Industrial facilities such as coal-fired power
plants have also been identified as emission
sources (10). In addition to direct emission,
some nitro-PAHs such as 2-nitrofluoran-
thene and 2-nitropyrene have been shown
to be formed from the reaction ofoxides of
nitrogen with hydroxyl radicals and poly-
cyclic aromatic hydrocarbons in ambient
air (11,12). Sources of nitro-PAH genera-
tion in the indoor environment include
kerosene heaters and gas and liquified
petroleum gas burners (13).
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The levels ofnitro-PAHs found in the
environment have been the subject of
numerous reports. Levels of 1,6-dinitropy-
rene ranged from 0.026 pg/m3 to 7.5 pg/m3
in various U.S. industrial, urban, and subur-
ban areas (14). Organic extracts from
coastal sediments offthe shore ofBarcelona
contained 1-nitropyrene, 6-nitrochrysene,
and 6-nitrobenzo[a]pyrene (15). Some
inferences regarding the importance of
nitro-PAHs to the total mutagenic load of
ambient atmospheres can be drawn from
the current database. The direct-acting
mutagenicity of the nitro-PAHs as com-
pared to the promutagenicity ofB[a]P and
other PAHs as seen in the Ames bioassay
have been well documented (11). Thus,
certain PAHs must be transformed meta-
bolically through a mammalian enzyme
system, while nitroaromatic compounds
can be reduced to the corresponding
N-hydroxy aromatic amine by the tester
strain without the addition ofmammalian
enzymes. Results from numerous studies
indicate that extracts ofpolycyclic organic
matter collected from cities in the United
States and Japan did not need mammalian
metabolic activation to be mutagenic;
therefore, these urban particles must con-
tain, in addition to promutagenic PAHs,
other direct-acting mutagens. Due to their
high mutagenic potency and their relative
levels in the air, the impact ofnitro-PAHs
on the environment needs to be addressed.
The mutagenic profiles of the extracts
were also found to vary according to the
presence of nitrogen dioxide, ozone, the
amount of organic carbon, and other
processes that potentially occur between
ambient aerosols and reactive gases. The
contribution of nitro-PAHs to the
mutagenicity of airborne extracts from
homes was evaluated in the Barcelona
study mentioned above. Nitro-PAHs
accounted for about 50% of the muta-
genicity of particulate from samples col-
lected from a home in the city. Similar
tests conducted in a rural home during
various particulate-generating activities
such as burning charcoal, smoking
tobacco, and cooking indicated that nitro-
PAHs accounted for a maximum of 33%
ofthe mutagenicity (16).
Metabolism ofNitro-PAH
Several of the nitro-PAH metabolic
pathways have been studied. Most clearly
defined are the metabolism of6-nitrochry-
sene and 1-nitropyrene. Generally, nitro-
PAH metabolism consists of activation by
ring- or N-oxidation, resulting in the
production of DNA adduct-forming and
mutagenic intermediates; detoxification
occurs by the formation ofring phenols.
6-Nitrochrysene is metabolized through
two possible routes, as shown in Figure 2
(17). The major pathway, which has been
demonstrated in mice, involves ring oxida-
tion producing trans-i,2-dihydro-1,2-dihy-
droxy-6-aminochrysene and subsequent
formation of 1,2-dihydroxy-3,4-epoxy-
1 ,2,3,4-tetrahydro-6-aminochrysene,
which forms a deoxyguanosine adduct
(18). The former reaction is catalyzed
by CYP1A2 and the latter by CYP3A4
in human liver microsomes (19). Inter-
estingly, the same study showed that
CYPlAl catalyzes the conversion of
6-nitrochrysene to trans-1,2-dihydro-1,2-
dihydroxy-aminochrysene in human
lung microsomes (19). Alternatively,
6-nitrochrysene can be reduced to the cor-
responding N-hydroxy-6-aminochrysene,
which is activated to an electrophilic nitre-
nium ion that forms adducts at the C8
position of deoxyadenosine (18). N-
Hydroxy-6-aminochrysene can also be
reduced by human liver CYP3A4 to 6-
aminochrysene, which is shunted into the
major pathway through formation of
002 OHNO;
OH
02
OH NO2
NH2
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f
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Figure 2. Metabolism of 6-nitrochrysene.
1,2-dihydroxy-3,4-epoxy- 1,2,3,4-tetra-
hydro-6-aminochrysene (19).
Recent studies indicate that 1-nitropy-
rene may follow a metabolic route similar
to that of6-nitrochrysene. While Howard
et al. (20) have shown that 1-nitropyrene is
ring-oxidized to the 6-ol and 8-ol by rabbit
CYP2C3 liver microsomes, Silvers et al.
(21) found that human liver microsome
P4503A4 oxidizes 1-nitropyrene to form
predominantly the 3-ol. It has been sug-
gested that in mice these oxide intermedi-
ates are conjugated with glutathione in the
liver. The conjugates are released into the
bile and converted to cysteine conjugates in
the upper intestinal tract. Finally, these are
degraded by cysteine conjugate 3-lyase of
the intestinal microflora in the lower
intestinal tract, and these reaction products
may result in formation ofa 1-nitropyrene
K-region epoxide adduct (22). It has also
been demonstrated that 1-nitropyrene can
alternatively be nitroreduced, and NADPH-
cytochrome C reductase has been suggested
to be responsible for this conversion in the
HepG2 cell line (23).
These data suggest that nitro-PAHs, as
well as the better studied PAHs, are present
in urban environments and that they make a
N -H
OH
Further
metabolism
DNA adducts
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significant contribution to the genotoxicity
of these environments. These compounds
can reach the lung where they can be meta-
bolically reduced or oxidized to electro-
philic species capable of binding to DNA
and other biological macromolecules. The
extent of human exposure and the bio-
logical effects, ifany, ofexposure to these
compounds have not yet been determined.
Biomonitoring for PAHs
and Nitro-PAHs
Measurement ofcarcinogen-DNA adducts
is an appropriate marker in the context of
disease prevention. Adducts form in target
tissues at elevated levels that approximately
reflect the increased risk for the particular
exposure. For example, adduct levels in the
lungs and urinary bladder ofsmokers were
proportional to the increased cancer risk in
those organs relative to the levels in con-
trols (24,25). DNA adduct levels have also
been shown to respond to exposure inter-
ventions. The levels in ex-smokers were
significantly lower than those in smokers
when sufficient time was allowed for
adducts to be cleared by cell turnover or
DNA repair. Finally, although adducts are
directly related to the disease process by
being the ultimate mutagens, the large size
of the genome, the relatively small size of
the critical targets, and the fact that DNA
repair occurs make it unlikely that any
specific DNA adduct will result in a tumor.
Thus, if exposure is reduced before critical
mutations, there will be a correspondingly
lower probability ofdisease.
NoninvasiveTechniques for
MonitoringDNAAdducts
Techniques to monitor carcinogen-DNA
adduct levels in humans have undergone
rapid development since their advent.
Early studies in humans employed surgi-
cal samples from target and other tissues.
As mentioned above, increased levels of
carcinogen-DNA adducts were seen in
lungs and urinary bladders of tobacco
smokers (24,25). Other studies ofpersons
with this exposure indicate that adduct
levels are elevated in the oral cavity, heart,
and placenta (26,27). Lung macrophages
obtained from smokers during bronchial
alveolar lavage (BAL) have not been
significantly elevated (26). On the other
hand, significant differences were noted in
BAL cells when persons were exposed
environmentally to smoky coal, a fuel
used for heating and cooking in some
areas of China, where there is a high rate
oflung cancer (28).
BloodLymphocytes in Monitoring
Environmental Exposure
Blood lymphocytes have potential as surro-
gates for measurement ofdamage in target
organs. Lymphocytes circulate throughout
the body and potentially contact circulating
carcinogens or their metabolites. They are
easily obtained through a blood sample.
These cells should integrate exposure over
their lifespan because they do not divide
until they are induced to do so in culture.
The lifespan of different lymphocytes is
variable, and this may have a profound
effect on their response. For example, Savela
and Hemminki (29) noted that there was
no statistically significant difference between
DNA adduct levels in crude lymphocytes
of smokers compared to nonsmokers.
However, when comparisons were made
on different cellular fractions, it was noted
that while the levels in the relatively short-
lived granulocytes (which account for 40 to
75% oftotal lymphocytes) were not differ-
ent between the groups, there was a 2.4-fold
higher level ofDNAadducts in theT leuko-
cytes of the smokers. We reported a case
study of an individual who was given
6-nitrochrysene as an antineoplastic agent
(17). The adducts in the lymphocytes of
this person appeared to co-chromatograph
with a 6-nitrochrysene-dihydrodiol-DNA
adduct standard prepared in vitro, suggest-
ing that ring oxidation may be more impor-
tant than nitroreduction for this compound.
As with any other surrogate tissue or
marker, it is important that the relationship
between the levels ofresponse in the surro-
gate be compared to that in the target.
Animal studies indicate that there might not
be a significant relationship between DNA
adducts in leukocytes and the target organs
for all compounds. B[a]P, the compound
often used to model effects for the larger
family ofPAHs, was shown to be the excep-
tion, as the levels of B[a]P-DNA adducts
were correlated with the levels in target tis-
sues (30). On the otherhand, Van Schooten
et al. (31) have shown that there was no
correlation between the individual adduct
levels in lymphocytes and surgical samples
ofthe lung in a series oflung cancer patients.
Thus, it appears difficult to generalize
regarding the utility ofwhite blood cell
adduct levels as a surrogate for the levels in
the target tissue. Animal and human studies
may be required to empirically determine
the relationship for anyparticular exposure.
ExfoliatedCellTechniques
Our approach to the issue of human
biomonitoring has been to exploit the
exfoliation of cells from lung and urinary
bladder. Lung and urinary bladder are two
major targets for occupational carcinogens.
And, while it is difficult to obtain samples
oftissues from these organs noninvasively,
we reasoned that since cells from the lung
and urinary bladder regularly exfoliate, it
might be possible to capture these cells and
use them to monitor exposure and effects
within the tissue. Although estimates vary
considerably, the lifespan of both urinary
bladder and lung cells has been reported as
about 100 days (32,33). We have shown
recently that certain DNA adduct levels in
exfoliated urothelial cells in cigarette smok-
ers were related to reported smoking his-
tory, urinary mutagenicity, and the levels
of4-aminobiphenyl-hemoglobin adducts
(34,35). We have also reported that the
levels ofcarcinogen-DNA adducts are sim-
ilar between bladder cancer cases and con-
trols and are related to smoking history
(36). We reported the results of a case
study in which a worker was accidentally
exposed to 4-4'-methylenebis(2-chloroani-
line) (MOCA). The MOCA-DNA adduct
levels in exfoliated urothelial cells of this
individual were extremely high immedi-
ately after exposure, then decreased rapidly,
probably as a function of the rapid loss of
highly exposed cells (37).
We recently studied a group ofworkers
exposed to benzidine and benzidine-based
dyes (38). Morning urine samples were
obtained from workers and controls and
analyzed for excretion ofbenzidine metabo-
lites, acetylation phenotype, and levels of
specific benzidine-DNA adducts in exfoli-
ated urothelial cells. We found that the
major DNA adduct in the exfoliated
urothelial cells of benzidine workers was
N-(deoxyguanosin-8-yl)-N'-acetylbenzi-
dine. The mean levels of this adduct were
about 20 times higher in the benzidine
production workers than in controls, but
only about twice as high in the benzidine
dye workers relative to the same compari-
son group. This study further supports the
use of this technique to noninvasively
biomonitor selected populations.
Because PAHs and nitro-PAHs reside
on the particulate fraction of combustion
products, it might be anticipated that the
lung, not the urinary bladder, is the major
target organ. In addition, the lung is capa-
ble of carrying out both the oxidative and
reductive metabolic reactions required to
activate these compounds. We have also
performed preliminary studies with cells
exfoliated from the lung and collected in
sputum samples. We have seen that in a
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very small sample (n = 3), the adducts in
DNA from cells collected in sputum
samples were qualitatively and quantita-
tively similar to the adducts in DNA from
cells obtained by brush biopsy from the
same individual.
Conclusion
Exposure to PAHs and nitro-PAHs in the
environment may have a significant impact
on certain individuals. Individuals at
particular risk are those who are exposed to
high levels of these compounds; those in
proximity to emissions from diesel equip-
ment, for example, as well as those who
may be predisposed metabolically to pro-
duction ofhigh levels ofgenotoxic metabo-
lites. Biological monitoring may likely
provide more pertinent information than
air sampling data because of the multiple
pathways ofexposure. Methods have been
developed to monitor the levels ofcarcino-
gen-DNA adducts in blood lymphocytes
and in exfoliated urothelial cells. These
techniques may prove to be mutually
exclusive or complementary and studies
should be done in exposed populations to
determine how adduct measurements in
these tissues are related.
REFERENCES
1. Parkinson DK. Steelworkers and coke ovens: epidemiological
aspects. In: Occupational Lung Disease (Gee L, Morgan KC,
Brooks SM, eds). New York:Raven Press, 1984;119-124.
2. Parkin DM, Pisani P, FerlayJ. Estimates ofthe worldwide inci-
dence of eighteen major cancers in 1985. Int J Cancer
54:594-606 (1993).
3. Boring CC, Squires TS, Tong T. Cancer statistics. Cancer J
Clin 43:7-26 (1993).
4. Samet JM, Lerchen ML. Proportion oflung cancer caused by
occupation: a critical review. In: Occupational Lung Disease
(Gee L, Morgan KC, Brooks SM, eds). New York:Raven Press,
1984;55-65.
5. Gibbs G, Horowitz I. Lung cancer mortality in aluminum
plant workers. Occup Med 21:347-353 (1977).
6. Gazdar AF, Carbone DP. The Biology and Molecular Genetics
ofLung Cancer. Austin, TX:R.G. Landes, 1991.
7. Bridborg K, Wagoner JK, Blejer HP. National Institute for
Occupational Safety and Health. Occupational Diseases: Guide
to Their Recognition, Cincinnati:National Institute for
Occupational Safety and Health, 1977.
8. Kang DH, Correa-Villasensor A, Breyssea PN, Strickland, PT.
Correlation ofurinary 1-hydroxypyrene glucuronide concentra-
tion between mothers and their children, Proc Annu Meet Am
Assoc Cancer Res 36s:107 (1995).
9. IARC. IARC Monographs. Vol 46: Diesel and Gasoline
Engine Exhausts and Some Nitroarenes. Lyon:International
Agency for Research on Cancer, 1989;41-58.
10. Harris WR, Chess EK, Okamoto D, Remsen JF, Later DW.
Contribution of nitropyrene to the mutagenic activity of coal
fly ash. Environ Mutagen 6:131-144 (1984).
11. Pitts JN. Nitration of gaseous polycyclic aromatic hydrocar-
bons in simulated and ambient urban atmospheres: a source of
mutagenic nitroarenes. Atmos Environ 21:2531-2547 (1987).
12. Pitts JN, Sweetman JA, Zielinska B, Winer AM, Atkinson R.
Determination of 2-nitrofluoranthene and 2-nitropyrene in
ambient particulate organic matter: evidence for atmospheric
reactions Atmos Environ 19:1601-1608 (1985).
13. Tokiwa H, Nakagawa R, Horikawa K. Mutagenic/carcinogenic
agents in indoor pollutants: the dinitropyrenes generated by
kerosene heaters and fuel gas and liquified petroleum gas burn-
ers. Mutat Res 157:39-47 (1985).
14. Gibson TL. Sources ofnitroaromatic mutagens in atmospheric
polycyclic organic matter. J Air Potl Control Assoc
36:1022-1025 (1986).
15. Fernandez P, Grifoll M, Solanas AM, Bayona JM, Albaiges J.
Bioassay-directed chemical analysis ofgenotoxic components in
coastal sediments. Environ Sci Technol 26:817-829 (1992).
16. Nardini B, Granella M, Clonfero E. Mutagens in indoor par-
ticulate. Mutat Res 322:193-202 (1994).
17. Delclos KB, Talaska G, Walker R. Metabolic activation of
6-nitrochrysene and 6-aminochrysene in vitro and in vivo. In:
Nitroarenes (Howard PC, ed). New York:Elselvier,
1990;295-307.
18. Li EE, Heflich RH, Bucci TJ, Manjanatha MG, Blaydes BS,
Delolos KB. Relationships of DNA adduct formation, K-ras
activating mutations and tumorigenic activities of6-nitrochry-
sene and its metabolites in the lungs of CD-1 mice.
Carcinogenesis 15:1377-1385 (1994).
19. Chae YH, Yun CH, Guengerich FP, Kadlubar FF, el-Bayoumy
GAK. Roles of human hepatic and pulmonary cytochrome
P450 enzymes in the metabolism ofthe environmental carcino-
gen 6-nitrochrysene. Cancer Res 59:2028-34 (1993).
20. Howard PC, McManus ME, Koop DR. The role of
cytochrome P450 2C3 in rabbit liver microsomal metabolism
of 1-nitropyrene and 3-nitrofluoranthene. J Biochem Toxicol
9:71-78 (1994).
21. Silvers KJ, Chazinski T, McManus ME, Bauer SL, Gonzalez
FJ, Gelboin HV, Maurel P, Howard PC. Cytochrome P450
3A4 (nifedipine oxidase) is responsible for the C-oxidative
metabolism of 1-nitropyrene in human liver microsomal sam-
ples. Cancer Res 52:6237-4623 (1992).
22. Kinouchi T, Kataoka K, Miyanishi K, Akimoto S, Ohnishi Y.
Role ofintestinal microflora in metabolism ofglutathione con-
jugates of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-
oxide. TohokuJ Exp Med 168:119-122 (1992).
23. Belisario MA, Arena AR, Pecce R, Borgia R, Staiano N, De
Lorenzo F. Effect of enzyme inducers on metabolism of
1-nitropyrene in human hepatoma cell line HepG2. Chem Biol
Interact 78:253-257 (1991).
24. Phillip DH, Hewer A, Martin CN, Garner RC, King MM.
Correlation ofDNA adduct levels in human lung with cigarette
smoking. Nature 336:790-792 (1988).
25. Talaska G, Al-Juburi AZSS, Kadlubar FF. Smoking-related car-
cinogen-DNA adducts in biopsy samples of human urinary
bladder: Identification of N-(deoxyguanosin-8-yl)-4-amino-
biphenyl as a major adduct. Proc Natl Acad Sci USA
88:5350-5354 (1991).
26. Lewtas J, Mumford J, Everson RB, Hulka B, Wilcosky T,
Kozumbo Wm, Thompson C, George M, Dobias L, Sram R,
Li X, Gallagher J. Comparison ofDNA adducts from exposure
to complex mixtures in various human tissues and experimental
systems. Environ Health Perspect 99:89-97 (1993).
27. Foiles PG, Miglietta LM, Quart AM, Quart E, Kabat GC,
Hecht SS. Evaluation of32P-postlabeling analysis ofDNA from
exfoliated oral mucosa cells as a means ofmonitoring exposure
of the oral cavity to genotoxic agents. Carcinogenesis
10:1429-1434 (1989).
28. Mumford JL, Lee X, Lewtas J, Young TL, Santella R. DNA
adducts as biomarkers for assessing exposure to polycyclic aro-
matic hydrocarbons in tissues from Xuan Wei women with
high exposure to coal combustion emissions and high lung
cancer mortality. Environ Health Perspect 99:83-87 (1993).
29. Savela K, Hemminki K. DNA adducts in leukocytes and gran-
ulocytes ofsmokers and nonsmokers detected by the 32P-post-
labeling assay. Carcinogenesis 12:503-508 (1991).
30. Reddy MV, Randerath K. A comparison of DNA adduct for-
mation in white blood cells and internal organs of mice
exposed to benzo[a]pyrene, dibenzo[cg]carbazole, safrole and
Environmental Health Perspectives * Vol 104, Supplement 5 * October 1996 905TALASKA ET AL.
cigarette smoke condensate. Mutat Res 241:37-48 (1990).
31. Van Schooten FJ, Hillebrand MJX, Van Leeuwen FE, Van
Zandwijk N, Jansen HM, den Engelse L, Kriek E. Polycyclic
aromatic hydrocarbon DNA adducts in white blood cells from
lung cancer patients: no correlation with adduct levels in lung.
Carcinogenesis 13:987-993 (1992).
32. Clayson DB, Lawson TA. Mechanisms ofbladder carcinogene-
sis. In: Carcinoma of the Bladder (Connolly JG, ed). New
York:Raven Press, 1987;91-100
33. Cotes JE, Steel J. Work-related Lung Disorders. Oxford:
Blackwell Scientific Press, 1987;436.
34. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso
N, Unruh L, Kadlubar F, Bartsch H, Malaveille, C, Vineis P.
Detection of carcinogen-DNA adducts in exfoliated urothelial
cells ofcigarette smokers: correlation with smoking, hemoglo-
bin adducts, and urinary mutagenicity. Cancer Epidemiol
Biomark Prevent 1:61-66 (1991).
35. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N,
Kadlubar F, Bartsch H, Malaveille C, Vineis P. Carcinogen-DNA
adducts in exfoliated urothelial cells: techniques for non-inva-
sive human monitoring. Environ Health Perspect 99:289-291
(1991).
36. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar
F, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G,
Tannenbaum SR. Genetically-based N-acetyltransferase meta-
bolic polymorphism and low level environmental exposure to
carcinogens. Nature 369:154-156 (1992).
37. Kaderlik KR, Talaska G, DeBord DG, Osorio AM, Kadlubar
FF. 4,4'-Methylene-bis(2-chloraniline)-DNA adduct analysis in
human exfoliated urothelial cells by 32P-postlabeling. Cancer
Epidemiol Biomark Prevent 2:63-69 (1993).
38. Rothman N, Bhatnagar UK, Hayes RB, Kashyap R, Parikh DJ,
Kashyap SK, Schucte PA, Butler MA, Jaeger M, Talaska G.
The impact ofN-acetyltransferase activity on benzidine urinary
metabolites and urothelial DNA adducts in exposed workers.
Proc Natl Acad Sci USA 93:5084-5089 (1996).
906 Environmental Health Perspectives * Vol 104, Supplement 5 * October 1996